Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.20.2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Accounts receivable, allowance for credit loss, current $ 980 $ 2,260
Total assets [1] $ 1,584,697 $ 1,374,013
Preferred stock, par value (in usd per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Variable Interest Entity, Primary Beneficiary    
Total assets $ 166,678 $ 158,912
Total liabilities $ 35,334 $ 38,568
Class A Common Stock    
Common stock, par value (in usd per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 31,967,870 31,331,345
Common stock, shares outstanding (in shares) 29,866,075 29,230,005
Treasury stock, shares (in shares) 2,101,795 2,101,340
Class B Common Stock    
Common stock, par value (in usd per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 144,000,000 144,000,000
Common stock, shares issued (in shares) 18,000,000 18,000,000
Common stock, shares outstanding (in shares) 18,000,000 18,000,000
[1] Includes restricted assets of consolidated variable interest entities (“VIEs”) at September 30, 2020 and December 31, 2019 of $166,678 and $158,912, respectively. Includes non-recourse liabilities of consolidated VIEs at September 30, 2020 and December 31, 2019 of $35,334 and $38,568, respectively. See Note 12.